Vireo Growth (VREOF) Raw Materials (2020 - 2026)
Vireo Growth (VREOF) reported Raw Materials of $11.3 million for Q1 2026, up 307.82% on a YoY basis from $2.8 million in Q1 2025, and up 20.21% sequentially from $9.4 million in Q4 2025.
Vireo Growth (VREOF) Raw Materials (2020 - 2026) Analysis & Trends
Vireo Growth (VREOF) has 7 years of Raw Materials data on file, last reported at $11.3 million in Q1 2026.
- For the quarter ending Q1 2026, Raw Materials rose 307.82% year-over-year to $11.3 million; the trailing twelve-month figure through Mar 2026 stood at $11.3 million (up 307.82% YoY), and the FY2025 full-year result was $9.4 million, up 401.62% from the prior year.
- Raw Materials grew to $11.3 million in Q1 2026, from $9.4 million in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $11.3 million in Q1 2026 to a low of $581193.0 in Q2 2023.
- A 5-year average of $2.6 million and a median of $921450.0 in 2024 frame the typical range for Raw Materials.
- Across the five-year window, Raw Materials tumbled 30.17% in 2023 and surged 506.12% in 2025, its largest moves.
- Tracing VREOF's Raw Materials over 5 years: stood at $791568.0 in 2022, then gained by 19.91% to $949191.0 in 2023, then soared by 97.42% to $1.9 million in 2024, then jumped by 401.62% to $9.4 million in 2025, then increased by 20.21% to $11.3 million in 2026.
- Business Quant data shows VREOF's Raw Materials at $11.3 million in Q1 2026, $9.4 million in Q4 2025, and $5.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.30 Mn |
| Dec 31, 2025 | 9.40 Mn |
| Sep 30, 2025 | 5.59 Mn |
| Jun 30, 2025 | 5.19 Mn |
| Mar 31, 2025 | 2.77 Mn |
| Dec 31, 2024 | 1.87 Mn |
| Sep 30, 2024 | 921,450.00 |
| Jun 30, 2024 | 998,022.00 |
| Mar 31, 2024 | 884,060.00 |
| Dec 31, 2023 | 949,191.00 |
| Sep 30, 2023 | 805,031.00 |
| Jun 30, 2023 | 581,193.00 |
| Mar 31, 2023 | 685,809.00 |
| Dec 31, 2022 | 791,568.00 |
| Sep 30, 2022 | 662,474.00 |
| Jun 30, 2022 | 832,326.00 |
| Mar 31, 2022 | 791,376.00 |
| Dec 31, 2021 | 674,381.00 |
| Dec 31, 2020 | 346,493.00 |